The TCR repertoire of an immunodominant CD8+ T lymphocyte population

被引:43
作者
Chen, ZW [1 ]
Li, YY [1 ]
Zeng, XJ [1 ]
Kuroda, MJ [1 ]
Schmitz, JE [1 ]
Shen, Y [1 ]
Lai, XM [1 ]
Shen, L [1 ]
Letvin, NL [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
D O I
10.4049/jimmunol.166.7.4525
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The TCR repertoire of an epitope-specific CD8(+) T cell population remains poorly characterized. To determine the breadth of the TCR repertoire of a CD8(+) T cell population that recognizes a dominant epitope of the AIDS virus, the CD8(+) T cells recognizing the tetrameric Mamu-A*01/p11C(CM) complex were isolated from simian immunodeficiency virus (SIV)-infected Mamu-A*01(+) rhesus monkeys. This CD8(+) T cell population exhibited selected usage of TCR V beta families and complementarity-determining region 3 (CDR3) segments. Although the epitope-specific CD8(+) T cell response was clearly polyclonal, a dominance of selected V beta (+) cell subpopulations and clones was seen in the TCR repertoire. Interestingly, some of the selected V beta (+) cell subpopulations and clones maintained their dominance in the TCR repertoire over time after infection with SIV of macaques. Other V beta (+) cell subpopulations declined over time in their relative representation and were replaced by newly evolving clones that became dominant. The present study provides molecular evidence indicating that the TCR repertoire shaped by a single viral epitope is dominated at any point in time by selected V beta (+) cell subpopulations and clones and suggests that dominant V beta (+) cell subpopulations and clones can either be stable or evolve during a chronic infection.
引用
收藏
页码:4525 / 4533
页数:9
相关论文
共 31 条
  • [1] PREFERENTIAL USAGE OF V-ALPHA-4 AND V-BETA-10 T-CELL RECEPTOR GENES BY LYMPHOCYTIC CHORIOMENINGITIS VIRUS GLYCOPROTEIN-SPECIFIC H-2DB-RESTRICTED CYTOTOXIC T-CELLS
    AEBISCHER, T
    OEHEN, S
    HENGARTNER, H
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (03) : 523 - 531
  • [2] Phenotypic analysis of antigen-specific T lymphocytes
    Altman, JD
    Moss, PAH
    Goulder, PJR
    Barouch, DH
    McHeyzerWilliams, MG
    Bell, JI
    McMichael, AJ
    Davis, MM
    [J]. SCIENCE, 1996, 274 (5284) : 94 - 96
  • [3] Bieganowska K, 1999, J IMMUNOL, V162, P1765
  • [4] VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    BORROW, P
    LEWICKI, H
    HAHN, BH
    SHAW, GM
    OLDSTONE, MBA
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6103 - 6110
  • [5] CONSERVATION OF T-CELL RECEPTOR USAGE BY HLA B27-RESTRICTED INFLUENZA-SPECIFIC CYTOTOXIC T-LYMPHOCYTES SUGGESTS A GENERAL PATTERN FOR ANTIGEN-SPECIFIC MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I-RESTRICTED RESPONSES
    BOWNESS, P
    MOSS, PAH
    ROWLANDJONES, S
    BELL, JI
    MCMICHAEL, AJ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (07) : 1417 - 1421
  • [6] T-CELL RECEPTOR V-BETA-GENE USAGE IN A HUMAN ALLOREACTIVE RESPONSE - SHARED STRUCTURAL FEATURES AMONG HLA-B27-SPECIFIC T-CELL CLONES
    BRAGADO, R
    LAUZURICA, P
    LOPEZ, D
    DECASTRO, JAL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (04) : 1189 - 1204
  • [7] QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE
    CARMICHAEL, A
    JIN, X
    SISSONS, P
    BORYSIEWICZ, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 249 - 256
  • [8] T-CELL RECEPTOR V-BETA REPERTOIRE IN AN ACUTE INFECTION OF RHESUS-MONKEYS WITH SIMIAN IMMUNODEFICIENCY VIRUSES AND A CHIMERIC SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS
    CHEN, ZW
    KOU, ZC
    LEKUTIS, C
    SHEN, L
    ZHOU, DJ
    HALLORAN, M
    LI, J
    SODROSKI, J
    LEEPARRITZ, D
    LETVIN, NL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 21 - 31
  • [9] Chen ZW, 1996, J IMMUNOL, V156, P1469
  • [10] CHEN ZW, 1993, J IMMUNOL, V151, P2177